We are thrilled to announce that RitSight, our 0.22% riboflavin ophthalmic solution for corneal cross-linking, has been granted the CE Certificate in conformity with the Medical Device Regulation (MDR)! This certification marks a significant step forward ...
Pre-clinical validation outcomes of theranostic-guided corneal cross-linking published
In a recent study published in the prestigious Journal of Cataract & Refractive Surgery, theranostic-guided corneal cross-linking has been confirmed to induce precise and predictive corneal tissue strengthening in eye-bank human donor tissues through ...